Stocktoria
SAB Biotherapeutics, Inc. SABS
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-01-12
SAB Biotherapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 3,095,197 | $11.6M | 5.05% |
| TWO SIGMA INVESTMENTS, LP | 181,185 | $693,939 | 0.3% |
| CITADEL ADVISORS LLC | 69,600 | $266,568 | 0.11% |
| BlackRock Finance, Inc. | 13,752 | $42,631 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.